47783-645 : Takhzyro 150 mg/ml Subcutaneous Solution


NDC: 47783-645
Labeler: Takeda Pharmaceuticals America, Inc.
Product Type: Human Prescription Drug
Drug Name:  Takhzyro
Dosage Form: Subcutaneous Solution
Application #: BLA761090
Rev. Date: 


NDC Package Codes:

  • 47783-645-01: 1 SYRINGE, GLASS IN 1 CARTON (47783‑645‑01) / 1 ML IN 1 SYRINGE, GLASS

Active Ingredients:

  • Lanadelumab

Dosage Strength:

  • 150 mg/mL

Pharmaceutical Classes:

  • Kallikrein Inhibitors [MoA]
  • Plasma Kallikrein Inhibitor [EPC]

Related Products:

Based on records with the same trade name.
  • 47783-646 Takhzyro 300 mg/2ml Subcutaneous Solution by Takeda Pharmaceuticals America, Inc.
  • 47783-644 Takhzyro 300 mg/2ml Subcutaneous Injection, Solution by Dyax Corp.

NDC QR Code

Scan the QR code below to easily reference this data in the future:

NDC 47783-645 QR Code

< Prev: 47783-644Next: 47783-646 >




Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.